This is a renewal of the existing Emory University Vaccinology Training Program T32 that was first funded in 2009. Emory is uniquely positioned to train a cadre of scientists with expertise in multi-disciplinary approaches to vaccines. The faculty preceptors have the breadth of expertise and mentoring experience that are critical for training a new generation of Vaccinologists. The preceptors are affiliated with several departments and programs at Emory, including the Emory Schools of Medicine and School of Public Health, the Emory Vaccine Center and the joint Emory-Georgia Institute of Technology (GA Tech) Biomedical Engineering Department at Emory. The preceptors have extensive training experience across several Vaccinology disciplines, including microbiology and immunology, infectious diseases, public health, pathology, pediatrics, epidemiology, behavior, global health, and health policy. This renewal application proposes support for five postdoctoral fellows (MD, PhD, or MD/PhD)-an increase of one fellow-to engage in full-time Vaccinology training. The fellows receive formal and informal education and career mentoring, and conduct mentored research. Our trainees acquire the skills and background necessary for their success as Vaccinology leaders in the future. Each trainee selects an in depth mentored research project with a preceptor from one of four Research Training Sections: 1) Pathogenesis &Vaccine Discovery;2) Innate &Adaptive Immune Responses to Bacterial, Protozoal, &Viral Antigens;3) Vaccine Epidemiology &Health Policy;and 4) Translation, Delivery &Clinical Trials. Every trainee participates in two required comprehensive graduate level courses emphasizing different aspects of the field of Vaccinology, and a third required course in Research Ethics. The specific goals of the Program include: """""""" To Inspire and attract outstanding post-doctoral trainees to pursue interdisciplinary training in preparation for independent vaccinology research careers; """""""" To integrate the strong basic science, translational research, and clinical trials programs at Emory into a multi-faceted training experience, producing a synergistic whole greater than the sum of its individual parts; """""""" To train MD and PhD scientists committed to careers in vaccine research to incorporate innovative basic science tools into Vaccinology and public health; """""""" To provide each trainee with formal and informal Vaccinology education, a mentoring team for his or her collaborative multidisciplinary research project, and career mentoring.

Public Health Relevance

This application responds to an urgent need to train a new generation of Vaccinologists. Vaccines have dramatically reduced the spread of infectious diseases, show great potential for preventing and controlling chronic conditions, and highly cost-effective. However, to achieve the full potential of vaccines and address difficulties that have hindered progress, a new generation of well-prepared scientists is needed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
2T32AI074492-06
Application #
8742703
Study Section
Microbiology and Infectious Diseases Research Committee (MID)
Program Officer
Robbins, Christiane M
Project Start
2007-07-01
Project End
2019-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Myers, Tanya R; McNeil, Michael M; Ng, Carmen S et al. (2017) Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015. Vaccine 35:1758-1763
Rouphael, Nadine G; Paine, Michele; Mosley, Regina et al. (2017) The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet 390:649-658
Aceituno, Anna M; Stanhope, Kaitlyn K; Rebolledo, Paulina A et al. (2017) Using a monitoring and evaluation framework to improve study efficiency and quality during a prospective cohort study in infants receiving rotavirus vaccination in El Alto, Bolivia: the Infant Nutrition, Inflammation, and Diarrheal Illness (NIDI) study. BMC Public Health 17:911
Boyoglu-Barnum, S; Todd, S O; Meng, J et al. (2017) Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. J Virol 91:
Phadke, Varun K; Jacob, Jesse T (2016) Marvelous but Morbid: Infective endocarditis due to Serratia marcescens. Infect Dis Clin Pract (Baltim Md) 24:143-150
Kabbani, Sarah; Jacob, Jesse T; Gaynes, Robert P et al. (2016) Decrease in Candida bloodstream infections in veterans in Atlanta. Am J Infect Control 44:488-90
Phadke, Varun K; Bednarczyk, Robert A; Salmon, Daniel A et al. (2016) Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis. JAMA 315:1149-58
Omer, Saad B; Phadke, Varun K; Bednarczyk, Robert A et al. (2016) Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness. J Infect Dis 213:1216-23
McCarthy, Natalie L; Gee, Julianne; Sukumaran, Lakshmi et al. (2016) Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults. Pediatrics 137:e20152970
Burke, Rachel M; Suchdev, Parminder S; Rebolledo, Paulina A et al. (2016) Predictors of Inflammation in a Cohort of Bolivian Infants and Toddlers. Am J Trop Med Hyg 95:954-963

Showing the most recent 10 out of 76 publications